NCT01290250

Brief Summary

The purpose of this study is to evaluate the effects of a new orange juice-based beverage enriched in fiber and selected phenolic compounds (mainly flavanones) on features of metabolic syndrome and cardiovascular disease risk factors related to inflammation and antioxidant defense system in overweight and obese adult humans. This study hypothesizes that consumption of an orange juice-based beverage enriched in fiber and selected phenolic compounds (mainly flavanones)would improve lipid levels and lipid metabolism,blood pressure and the Homeostatic Model Assessment (HOMA) index.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
210

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2010

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

December 21, 2010

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2011

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 4, 2011

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2012

Completed
Last Updated

March 15, 2013

Status Verified

March 1, 2013

Enrollment Period

11 months

First QC Date

December 21, 2010

Last Update Submit

March 14, 2013

Conditions

Outcome Measures

Primary Outcomes (7)

  • Systolic blood pressure

    3 months

  • Fasting Plasma Insulin Concentration

    3 months

  • Fasting Plasma Triacylglycerols Concentration

    3 months

  • Fasting Plasma High-Density Lipoprotein Cholesterol Concentration

    3 months

  • Insulin resistance using HOMA (Homeostatic Model Assessment)index

    The HOMA index will be calculated as the product of the fasting plasma insulin level (mU/mL) and the fasting plasma glucose level (mmol/L), divided by 22.5

    3 months

  • Fasting Plasma glucose concentrations

    3 months

  • Diastolic blood pressure

    3 months

Secondary Outcomes (5)

  • Antioxidant defense system

    3 months

  • Biomarkers of inflammation

    3 months

  • Biomarkers of cardiovascular risk.

    3 months

  • Metabolic analysis

    3 months

  • Gene expression analysis

    3 months

Study Arms (2)

Orange juice based beverage enriched in polyphenols

EXPERIMENTAL

2 daily doses (250 ml each) during 3 months

Other: Orange juice based beverage enriched in polyphenols

Orange juice with low levels of polyphenols

PLACEBO COMPARATOR

2 daily doses (250 ml each) during 3 months

Other: Orange juice based beverage enriched in polyphenols

Interventions

2 daily doses (250 ml each) during 3 months

Orange juice based beverage enriched in polyphenolsOrange juice with low levels of polyphenols

Eligibility Criteria

Age30 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Body mass index (BMI) higher than 25 (overweight or obese) but lower than 40 (extreme obesity) or waist circumference higher than 94 cm for men and 80 cm for women,
  • and having altered at least two markers of MS namely:
  • Hypertension (diastolic pressure higher than 85 mmHg but lower than 110 mmHg)
  • Hyperglycemia (higher than 100 mg/dl but lower than 130 mg/dl)
  • Elevated plasma triacylglycerol concentrations (higher than 150 mg/dl)
  • Decreased plasma HDL-c levels (lower than 40 for men and 50 for women)
  • Volunteers will be otherwise healthy and without taking any medication aiming to lower either blood lipids, blood pressure or blood glucose concentrations.

You may not qualify if:

  • The presence of morbid obesity
  • Blood pressure higher than 110 mmHg
  • Plasma glucose levels higher than 130 mg/dl
  • The use of any medication for the control of blood pressure or glucose or lipid metabolism
  • Medical history of consumption of hypocaloric diet in the last year
  • Disorders of the food conduct
  • The presence of familiar dislipemias relatives of genetic character or the denial to take part in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Biochemistry and Molecular Biology II, Institute of Nutrition and Food Technology, Center for Biomedical Research, University of

Granada, Granada, 18071, Spain

Location

Related Publications (1)

  • Rangel-Huerta OD, Aguilera CM, Martin MV, Soto MJ, Rico MC, Vallejo F, Tomas-Barberan F, Perez-de-la-Cruz AJ, Gil A, Mesa MD. Normal or High Polyphenol Concentration in Orange Juice Affects Antioxidant Activity, Blood Pressure, and Body Weight in Obese or Overweight Adults. J Nutr. 2015 Aug;145(8):1808-16. doi: 10.3945/jn.115.213660. Epub 2015 Jul 1.

MeSH Terms

Conditions

OverweightObesity

Interventions

Polyphenols

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Officials

  • Concepcion Aguilera, Phd

    Universidad de Granada

    PRINCIPAL INVESTIGATOR
  • Maria Dolores Mesa, PhD

    Universidad de Granada

    PRINCIPAL INVESTIGATOR
  • Angel Gil, PhD

    Universidad de Granada

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Biochemistry and Molecular Biology

Study Record Dates

First Submitted

December 21, 2010

First Posted

February 4, 2011

Study Start

February 1, 2010

Primary Completion

January 1, 2011

Study Completion

July 1, 2012

Last Updated

March 15, 2013

Record last verified: 2013-03

Locations